LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to treat severe ...
According to the latest research by Future Market Insights, the glucagon injectable market is set to experience 5.4% growth during the year 2021-2031. Glucagon is a hormone that mobilizes the glucose ...
CHICAGO & DUBLIN--(BUSINESS WIRE)-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ...
IT has been shown in this and other laboratories that the administration of glucagon will produce an intense but temporary diabetes in force-fed rats and in human subjects. 1–3 However, a diabetes ...
To investigate the pathophysiology of glycogenoses of the liver, glycerol, an endogenous precursor of glucose, was administered intravenously to eight patients and to 22 control subjects. Its disposal ...
Fresenius Kabi announced the launch of Glucagon for Injection, which is indicated for use as a diagnostic aid during radiologic examinations. Glucagon increases blood glucose concentration and is used ...
Glucagon 1mg/0.2mL; soln for IV inj. Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). Do not refrigerate or freeze. Do not expose to extreme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback